Buprenorphine Hcl Tablet
Product Images NDC 67296-2123

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl (NDC 67296-2123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem-fig (Bup HCl Chem Fig)

FDA Label Image

Ifu-image (Ifu Image)

FDA Label Image

Buprenorphine-sl-tabs-bl-2mg-c50000233-03-k02 (Image 01)

Buprenorphine-sl-tabs-bl-2mg-c50000233-03-k02 (Image 01)
- This text is providing information about buprenorphine tablets containing 216 mg of buprenorphine HCI, USP, equivalent to 2 mg of buprenorphine base. - The usual dosage information is advised to be checked in the Package Insert for Complete Prescribing Information. - Storage instructions recommend keeping the tablets at 20° to 25°C (68° to TPF) room temperature. - The tablets are distributed by Hikma Pharmaceuticals USA Inc. in Berkeley Heights, NJ. - The NDC code for the tablets is 0054-0176-13 for a package of 30 tablets. - The tablets are described as Buprenorphine Sublingual Tablets of 2mg strength. - Pharmacists are instructed to dispense the tablets with the attached Medication Guide to ensure safe use. - A warning is given that children accidentally taking buprenorphine will need emergency medical care, emphasizing the importance of keeping the medicine out of the reach of children.*
FDA Label Image

Buprenorphine-sl-tabs-bl-8mg-c50000232-02-k02 (Image 02)

Buprenorphine-sl-tabs-bl-8mg-c50000232-02-k02 (Image 02)
Each tablet contains 8.64 mg of buprenorphine HCI, USP, equivalent to 8 mg of buprenorphine base. The usual dosage should be followed as per the package insert. Store the tablets at 20°C to 25°C (68°F to 77°F). Distributed by Hikma Pharmaceuticals USA Inc., these sublingual tablets are intended for use. Pharmacists should dispense with the attached Medication Guide and ensure children do not accidentally consume the drug, as it may require emergency medical care. The product comes in a pack of 30 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.